Lifeway Foods® Delivers Highest Quarterly Net Sales in Company History, Extending Record Growth in Second Quarter 2026
Lifeway Foods, Inc. (LWAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeway Foods® Delivers Highest Quarterly Net Sales in Company History, Extending Record Growth in Second Quarter 2026 $66.9 million in net sales, up 24.1% year-over-year and $3.9 million above the prior quarterly record 27th consecutive quarter of year-over-year net
How this was made
The 30-second read
Why it matters
Traders can update models for revenue growth durability, margin sensitivity to milk and packaging/transport costs, and the expected timing of gross margin and profitability recovery in 2027.
Market read
Record quarterly net sales growth contrasts with sharp gross margin compression, while management expects normalization and full margin recovery in 2027 alongside distribution gains and Waukesha expansion.
What to watch
SG&A as a percent of sales rose to 18.4% in Q2, so operating leverage may be slower than revenue growth implies; also, the Waukesha expansion is planned for early 2027, so execution risk could affect the recovery path.
Background
SEC Form 8-K Item 2.02 with Exhibit 99.1 press release covering Lifeway Foods Q2 2026 results and financial condition.
Ticker impact
Lifeway reports Q2 2026 net sales of $66.9M (+24.1% YoY) but gross margin falls to 19.5% from 28.6% due to elevated milk prices.
Likely positive bias on revenue momentum, with potential volatility as traders weigh margin compression and the credibility/timing of 2027 gross margin recovery.
This is a primary earnings-style disclosure with specific quarterly and YTD figures plus explicit forward-looking statements about margin recovery in 2027 and a Waukesha expansion timeline in early 2027.
Market effects
Highlights cost-driven margin pressure in cultured dairy/probiotic foods and the importance of pricing power and packaging/transport cost pass-through.
Limited direct regional read-through beyond US dairy input cost dynamics.
Low; primarily US-focused distribution and conventional milk cost outlook references.
Counterpoint
Margin recovery in 2027 is guidance, not a realized datapoint; if milk prices or resin/transport costs stay elevated longer, earnings leverage could disappoint despite strong top-line growth.
Key entities
- companyLifeway Foods, Inc.
Nasdaq-listed kefir and fermented probiotic foods supplier reporting Q2 2026 results and 2027 margin recovery expectations.
- executiveJulie Smolyansky
President and CEO quoted on record net sales, temporary margin headwind, and 2027 recovery outlook.